Source: LaingBuisson

Indigo: Belgium: Indigo Diabetes closes 38 m Series B funding

Medtech company Indigo Diabetes has closed its €38m (US$44.8m) Series B funding to help develop its glucose monitoring sensor for people with diabetes. The funding round was led by Fund+, with the participation of Ackermans & van Haaren, imec.xpand, Capricorn Digital Growth Fund, QBICII, Titan Baratto and the Series A investors. The company received strong [...]

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Danae Delbeke's photo - Founder & CEO of Indigo

Founder & CEO

Danae Delbeke

CEO Approval Rating

90/100

Read more